0001667234-19-000003.txt : 20190503 0001667234-19-000003.hdr.sgml : 20190503 20190503152737 ACCESSION NUMBER: 0001667234-19-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190503 DATE AS OF CHANGE: 20190503 EFFECTIVENESS DATE: 20190503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amalgam Rx, Inc. CENTRAL INDEX KEY: 0001667234 IRS NUMBER: 811299543 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-289825 FILM NUMBER: 19795865 BUSINESS ADDRESS: STREET 1: 1007 N. MARKET STREET STREET 2: SUITE 400 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 983 0001 MAIL ADDRESS: STREET 1: 1007 N. MARKET STREET STREET 2: SUITE 400 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: iSage Rx, Inc. DATE OF NAME CHANGE: 20160217 D/A 1 primary_doc.xml X0708 D/A LIVE 0001667234 Amalgam Rx, Inc. 1007 N. MARKET STREET SUITE 400 WILMINGTON DE DELAWARE 19801 302 983 0001 DELAWARE iSage Rx, Inc. Corporation true 2016 Ryan A Sysko 1007 N. Market Street Suite 400 Wilmington DE DELAWARE 19801 Executive Officer Director Sarwar Islam 1007 N. Market Street Suite 400 Wilmington DE DELAWARE 19801 Director Other Health Care Decline to Disclose 06b true 0001667234-19-000002 2017-06-16 true true false 0 Steven Sarigianis 1526658 None None 5090 South Exeter Street Suite 210 Baltimore MD MARYLAND 21202 MD MARYLAND NJ NEW JERSEY false 2000000 1223886 776114 false 27 0 9388 true Estimate is based on the issuer's good faith valuation of the finders' fee, which was paid other than in cash. 0 false Amalgam Rx, Inc. Ryan A. Sysko Ryan A. Sysko President and CEO 2019-05-02